文献速递心脏核医学

射血分数降低心力衰竭患者右心室葡萄糖代谢定量评估的临床意义

Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-08-13

结果显示右心室MRGlu与右心室压力负荷指标正相关,但与LVEF不相关;较高的左右心室MRGlu、LVEF≤16%及左室舒张末期容积≥209 ml与较差的总体生存和心脏结局相关。

要点

  • 右心室MRGlu与三尖瓣反流峰值压差及峰值流速正相关,提示与右心室压力负荷相关。
  • 右心室MRGlu与LVEF无明显相关,而LVEF与左室MRGlu正相关。
  • 较高的左右心室MRGlu、LVEF≤16%及左室舒张末期容积≥209 ml与不良预后相关。

核心结论

  • 在冠心病合并缺血性心肌病患者中,右心室葡萄糖利用率与右心室压力负荷正相关,但与LVEF不相关。
  • 整体左、右心室MRGlu、LVEF及左室舒张末期容积显示出显著的预后价值。

研究设计与样本

  • 分析整体左、右心室MRGlu(μmol/min/100 g),并通过电子病历独立评估结局事件。
  • 采用Kaplan-Meier生存分析评估FDG PET表现与结局的关联。

主要发现

  • 右心室与左心室MRGlu比值(RV/LV MRGlu)平均为89.5±264.9%(r=0.77,p<0.001)。
  • 右心室MRGlu与最大三尖瓣反流峰值压差(r=0.28,p=0.033)及峰值三尖瓣反流射流速度(r=0.29,p=0.021)正相关。
  • LVEF与左室MRGlu正相关(r=0.27,p=0.018),与舒张末期容积(r=-0.37,p=0.001)、收缩末期容积(r=-0.54,p<0.001)及RV/LV MRGlu(r=-0.40,p<0.001)负相关。
  • 右心室MRGlu与LVEF相关性不佳。

关键数值与推荐

  • 较高的右心室和左心室MRGlu值、LVEF≤16%以及门控PET测得的左室舒张末期容积≥209 ml与较差的总体生存和心脏结局相关。

临床怎么用

  • 动态18F-FDG PET定量评估左右心室MRGlu可用于冠心病合并缺血性心肌病患者的风险分层。
  • 右心室MRGlu升高提示右心室压力负荷增加,需关注右心功能及预后。
  • 结合LVEF≤16%和左室舒张末期容积≥209 ml等指标可识别高危患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dynamic 18F-fluorodeoxyglucose (FDG) PET can be used to quantitatively assess the rate of myocardial glucose uptake (MRGlu). The aim of this study was to evaluate the clinical significance and prognostic value of right ventricular (RV) MRGlu in patients with coronary artery disease and heart failure with reduced ejection fraction. METHODS: Patients with left ventricular ejection fraction (LVEF) ≤ 40% were consecutively enrolled for FDG PET between November 2012 and May 2017. Global LV and RV MRGlu (μmol/min/100 g) were analyzed. Outcome events were independently assessed using electronic medical records to determine hospitalization for revascularization, new-onset ischemic events, heart failure, cardiovascular, and all-cause death. Differences between LV and RV MRGlu and associations with clinical characteristics and echocardiographic data were evaluated. Associations among FDG PET findings and outcomes were analyzed using Kaplan-Meier survival analysis. RESULTS: Seventy-five patients (mean age 62.2 ± 12.7 years, male 85.3%, LVEF 19.3 ± 8.6%) were included for analysis. The mean glucose utilization ratio of RV-to-LV (RV/LV MRGlu) was 89.5 ± 264.9% (r = 0.77, p < 0.001). Positive correlations between RV MRGlu and maximal tricuspid regurgitation peak gradient (r = 0.28, p = 0.033) and peak tricuspid regurgitation jet velocity (r = 0.29, p = 0.021) were noted. LVEF was positively correlated with LV MRGlu (r = 0.27, p = 0.018), but negatively correlated with end-diastolic volume (r = - 0.37, p = 0.001), end-systolic volume (r = - 0.54, p < 0.001), and RV/LV MRGlu (r = - 0.40, p < 0.001). However, RV MRGlu was not well correlated with LVEF. Forty-three patients received revascularization procedures after FDG PET, and 13 patients died in a mean follow-up period of 496 ± 453 days (1-1788 days), including nine cardiovascular deaths. Higher RV and LV MRGlu values, LVEF ≤ 16% and LV end-diastolic volume ≥ 209 ml of gated-PET were associated with poor overall survival and cardiac outcomes. CONCLUSIONS: In patients with coronary artery disease and ischemic cardiomyopathy, RV glucose utilization was positively correlated with RV pressure overload, but not LVEF. Global LV and RV MRGlu, LVEF, and LV end-diastolic volume showed significant prognostic value.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Tsai SY, Wu YW, Wang SY, et al. Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction. Eur J Nucl Med Mol Imaging. 2019. PMID: 31410543. doi:10.1007/s00259-019-04471-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。